Pictet Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Pictet Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,500	Closed	-$445K	–	2219
2026 Q1	$445K	Sell	1,500 -200	-12%	-$64.7K	﹤0.01%	1524
2025 Q4	$516K	Hold	1,700	–	–	﹤0.01%	1428
2025 Q3	$579K	Hold	1,700	–	–	﹤0.01%	1322
2025 Q2	$412K	Buy	1,700 +810	+91%	+$199K	﹤0.01%	1453
2025 Q1	$242K	Sell	890 -100,639	-99%	-$23.5M	﹤0.01%	1719
2024 Q4	$18.8M	Sell	101,529 -6,600	-6%	-$1.35M	0.02%	521
2024 Q3	$23.6M	Sell	108,129 -702	-0.6%	-$126K	0.03%	446
2024 Q2	$15.5M	Sell	108,831 -55,493	-34%	-$8.55M	0.02%	534
2024 Q1	$25.7M	Buy	164,324 +25,362	+18%	+$4.08M	0.03%	432
2023 Q4	$25.1M	Buy	138,962 +10,000	+8%	+$1.81M	0.03%	424
2023 Q3	$23.2M	Buy	+128,962	New	+$25.5M	0.03%	420

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Pictet Asset Management's ONC Position: Q2 2026 in Review

Pictet Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 1,500 shares — an estimated $445K sold.

Pictet Asset Management first reported a position in ONC in Q3 2023 and held it in 11 quarters. The position peaked at $25.7M in Q1 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Pictet Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
Pictet Asset Management sold 1,500 BeOne Medicines Ltd shares in Q2 2026, an estimated $445K.
Pictet Asset Management first reported a position in BeOne Medicines Ltd in Q3 2023 and held it in 11 quarters.
Pictet Asset Management's BeOne Medicines Ltd position peaked at $25.7M in Q1 2024.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.